<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05792046</url>
  </required_header>
  <id_info>
    <org_study_id>NVOC-2023-02</org_study_id>
    <nct_id>NCT05792046</nct_id>
  </id_info>
  <brief_title>IMOvifa Perimeter Reference Database</brief_title>
  <official_title>IMOvifa Perimeter Reference Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New View Optometric Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New View Optometric Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will collect data to establish a reference database for the IMOvifa perimeter.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will collect data from a reference population to be used as inputs to the&#xD;
      calculation of age corrected significance limits for expected visual function sensitivity to&#xD;
      establish reference limits for key output parameters for select test patterns of the IMOvifa&#xD;
      perimeter device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 1, 2023</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reference limit for mean deviation</measure>
    <time_frame>Day 1</time_frame>
    <description>Visual sensitivity level in decibels</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Normal Eyes</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Subjects with normal visual function</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Visual field</intervention_name>
    <description>test for detecting loss in visual function</description>
    <arm_group_label>Normal</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Persons with normal visual function&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  22 years of age or older on the date of informed consent&#xD;
&#xD;
          -  Able to understand the written informed consent and willing to participate&#xD;
&#xD;
          -  IOP â‰¤ 21 mmHg (each eye)&#xD;
&#xD;
          -  BCVA 20/40 or better (each eye)&#xD;
&#xD;
          -  Both eyes free of ocular conditions that may affect visual function (at doctor's&#xD;
             discretion)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to tolerate ophthalmic imaging and/or VF testing&#xD;
&#xD;
          -  History of conditions known to adversely affect visual function (at doctor discretion)&#xD;
&#xD;
          -  Spherical Equivalent refractive error outside the range from +6 Diopters&#xD;
&#xD;
          -  Cylindrical refractive error outside the range +2.5 Diopters&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Topcon Healthcare Innovation Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New View Optometric Center</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 17, 2023</study_first_submitted>
  <study_first_submitted_qc>March 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 30, 2023</last_update_submitted>
  <last_update_submitted_qc>March 30, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

